栀子苷通过抑制环氧合酶2及减弱p53信号通路在大鼠诱导性心肌梗死中的潜在心脏保护作用
该研究用Sprague-Dawley大鼠建立心肌梗死模型,心肌梗死后给予栀子苷治疗5周,进行形态学和血流动力学测量及生物学与分子实验。结果发现模型组收缩期和舒张期形态学与血流动力学均显著受损,栀子苷治疗后恢复至接近基线水平;栀子苷还使心肌梗死后上调的细胞色素c、p53、COX2、PGD2表达及下调的MDM2表达恢复至接近基线。栀子苷通过抑制凋亡和炎症通路预防心肌梗死后结构-功能重构。作者认为该研究揭示了栀子苷的心脏保护机制,并暗示其用于治疗缺血性心力衰竭的潜在临床应用价值。
要点
- 正常Sprague-Dawley大鼠制成心肌梗死模型后给予栀子苷治疗5周,收缩期和舒张期形态学与血流动力学指标恢复至接近基线水平。
- 心肌梗死模型组细胞色素c、p53、COX2、PGD2表达上调、MDM2表达下调,栀子苷治疗使上述表达恢复至接近基线。
- 栀子苷通过抑制凋亡和炎症通路预防心肌梗死后结构-功能重构。
- 作者认为该研究暗示栀子苷治疗缺血性心力衰竭的潜在临床应用价值。
适用人群与场景
- 正常Sprague-Dawley大鼠制成的心肌梗死模型,心肌梗死后接受栀子苷治疗5周。
处置流程与药物剂量
- 心肌梗死后给予栀子苷治疗5周,具体剂量、给药途径和频次原文未写明。
研究设计与关键结果
- 研究类型为动物实验:正常Sprague-Dawley大鼠制成心肌梗死模型,栀子苷治疗5周后测量形态学和血流动力学。
- 模型组收缩期和舒张期形态学与血流动力学均显著受损,栀子苷治疗后恢复至接近基线水平。
- 栀子苷使心肌梗死后上调的细胞色素c、p53、COX2、PGD2表达及下调的MDM2表达恢复至接近基线。
- 栀子苷抑制凋亡和炎症通路,预防心肌梗死后结构-功能重构。
证据类型、等级与局限
- 证据类型:动物实验(大鼠心肌梗死模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为该研究暗示栀子苷治疗缺血性心力衰竭的潜在临床应用价值。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background and aims: Genipin, an iridoid derived from geniposide by β-glucosidase hydrolysis, has shown potential benefit in the treatment of heart function insufficiency despite its unclear therapeutic mechanism. This study aimed to investigate the primary cardioprotective mechanism of genipin. We hypothesized that genipin demonstrated the antiapoptosis and anti-inflammation for cardiac protection by inhibiting the cyclooxidase 2 (COX2)-prostaglandin D2 (PGD2) and murine double minute 2 (MDM2)-p53 pathways. Methods: The normal Sprague-Dawley rats were made into myocardial infarction models by conventional methods. Animals were treated with genipin for 5 weeks after myocardial infarction (MI). Morphometric and hemodynamic measurements were performed 5 weeks post-MI. Biological and molecular experiments were performed after the termination. Results: Both morphometry and hemodynamics in systole and diastole were significantly impaired in the model group but restored close to basal level after treatment with genipin. Genipin also restored the post-MI upregulated expressions of cytochrome c, p53, COX2, and PGD2 and downregulated expression of MDM2 to the approximate baseline. Genipin inhibited apoptotic and inflammatory pathways to prevent post-MI structure-function remodeling. Conclusions: This study showed the cardioprotective mechanism of genipin and implied its potential clinical application for the treatment of ischemic heart failure.
参考来源
- Zhao L, Sun L, Li X, et al. POTENTIAL CARDIOPROTECTIVE EFFECT OF GENIPIN VIA CYCLOOXIDASE 2 SUPPRESSION AND P53 SIGNAL PATHWAY ATTENUATION IN INDUCED MYOCARDIAL INFARCTION IN RATS. Shock. 2022. PMID: 36445232. doi:10.1097/SHK.0000000000002001
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。